Portfolio

 

CARMEL PHARMA

Intellectual property that focuses on the reformulation of approved drugs.

CAR-501 - PREXXARTAN™ Valsartan Oral Solution, 4 mg/mL (NDA Approval Dec. 2017)

CAR-503 and CAR-504 Projects

CAR-505, CAR-506, CAR-507, and CAR-508 Projects

CAR-509, CAR-510, CAR-511, and CAR-512 Projects

 

CARMEL ANDA

FDA-Approved generic drugs that are poised to sell to hospital, medical offices, and pharmacies.

CAR-513, CAR-514, and CAR-515 Projects

 

CARMEL BIOHEALTH

Nutraceutical products that maintain cardiovascular and metabolic health

CAR-191, CAR-192, CAR-193, and CAR-194 Projects

 

ATLANTA CLINICAL and RESEARCH

An existing medical practice and clinical research center that has contracts and agreements with government agencies, third party insurance companies, and clinical trial sponsors.

 

tod's cyber monday